Phagocytic function in patients with recurrent urinary tract infections. 1992

A Tambić, and P Kes, and S Milutinović, and S Rabatić, and V Silobrcić
General Hospital Sveti Duh, University Hospital Sestre milosrdnice, Zagreb, Croatia.

Phagocytes play an essential role in the host's defence against uropathogenic bacteria which are mostly extracellular pathogens. The functional capacity of peripheral blood phagocytes (predominantly polymorphonuclears, PMN) was investigated in 47 patients (urethrocystitis, acute or chronic pyelonephritis) and in healthy persons. The random mobility of phagocytes was determined by measuring their spontaneous migration from a capillary tube. Using radioactively labelled sheep erythrocytes as targets and the phagocytes as effector cells, ingestion, digestion and extracellular cytotoxicity were determined. All the four phagocytic functions in patients were significantly lower than in healthy controls, especially in patients with chronic pyelonephritis. These results link reduced phagocytosis by blood phagocytes with recurrent urinary tract infections (UTI). Whether the defect is primary or secondary to infection (and only transient) should be the object of further studies.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010586 Phagocytes Cells that can carry out the process of PHAGOCYTOSIS. Phagocyte,Phagocytic Cell,Phagocytic Cells,Cell, Phagocytic,Cells, Phagocytic
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000920 Antibody-Dependent Cell Cytotoxicity The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a "killer" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. ADCC,Cytotoxicity, Antibody-Dependent Cell,Cell Cytoxicity, Antibody-Dependent,Antibody Dependent Cell Cytotoxicity,Antibody-Dependent Cell Cytotoxicities,Antibody-Dependent Cell Cytoxicities,Antibody-Dependent Cell Cytoxicity,Cell Cytotoxicities, Antibody-Dependent,Cell Cytotoxicity, Antibody-Dependent,Cell Cytoxicities, Antibody-Dependent,Cell Cytoxicity, Antibody Dependent,Cytotoxicities, Antibody-Dependent Cell,Cytotoxicity, Antibody Dependent Cell,Cytoxicities, Antibody-Dependent Cell,Cytoxicity, Antibody-Dependent Cell

Related Publications

A Tambić, and P Kes, and S Milutinović, and S Rabatić, and V Silobrcić
January 1989, Przeglad lekarski,
A Tambić, and P Kes, and S Milutinović, and S Rabatić, and V Silobrcić
October 2003, Urological research,
A Tambić, and P Kes, and S Milutinović, and S Rabatić, and V Silobrcić
December 2005, Best practice & research. Clinical obstetrics & gynaecology,
A Tambić, and P Kes, and S Milutinović, and S Rabatić, and V Silobrcić
November 1988, Giornale di clinica medica,
A Tambić, and P Kes, and S Milutinović, and S Rabatić, and V Silobrcić
December 1988, The Western journal of medicine,
A Tambić, and P Kes, and S Milutinović, and S Rabatić, and V Silobrcić
December 2005, Enfermedades infecciosas y microbiologia clinica,
A Tambić, and P Kes, and S Milutinović, and S Rabatić, and V Silobrcić
April 2016, American family physician,
A Tambić, and P Kes, and S Milutinović, and S Rabatić, and V Silobrcić
June 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
A Tambić, and P Kes, and S Milutinović, and S Rabatić, and V Silobrcić
October 2015, The Journal of urology,
A Tambić, and P Kes, and S Milutinović, and S Rabatić, and V Silobrcić
January 2022, Vnitrni lekarstvi,
Copied contents to your clipboard!